Literature DB >> 15456872

Alix/AIP1 antagonizes epidermal growth factor receptor downregulation by the Cbl-SETA/CIN85 complex.

Mirko H H Schmidt1, Daniela Hoeller, Jiuhong Yu, Frank B Furnari, Webster K Cavenee, Ivan Dikic, Oliver Bögler.   

Abstract

The assembly of the Cbl-SETA/CIN85-endophilin complex at the C terminus of the epidermal growth factor receptor (EGFR) following ligand activation mediates its internalization and ubiquitination. We found that the SETA/CIN85-interacting protein Alix/AIP1, which also binds endophilins, modulates this complex. Alix was found to associate indirectly with EGFR, regardless of its activation state, and with DeltaEGFR, which signals at low intensity and does not bind Cbls or SETA/CIN85. In agreement with this, Alix interaction did not occur via SETA/CIN85. However, SETA/CIN85 and Alix were capable of mutually promoting their interaction with the EGFR. Increasing the level of Alix weakened the interaction between SETA/CIN85 and Cbl and reduced the tyrosine phosphorylation of c-Cbl and the level of ubiquitination of EGFR, SETA/CIN85, and Cbls. This antagonism of the Cbl-SETA/CIN85 complex by Alix was reflected in its diminution of EGFR internalization. In agreement with this, small interfering RNA-mediated knockdown of Alix promoted EGFR internalization and downregulation. It has been suggested that SETA/CIN85 promotes receptor internalization by recruiting endophilins. However, Alix was also capable of increasing the level of endophilin associated with EGFR, implying that this is not sufficient to promote receptor internalization. We propose that Alix inhibits EGFR internalization by attenuating the interaction between Cbl and SETA/CIN85 and by inhibiting Cbl-mediated ubiquitination of the EGFR.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15456872      PMCID: PMC517880          DOI: 10.1128/MCB.24.20.8981-8993.2004

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  47 in total

1.  Role of LBPA and Alix in multivesicular liposome formation and endosome organization.

Authors:  Hirotami Matsuo; Julien Chevallier; Nathalie Mayran; Isabelle Le Blanc; Charles Ferguson; Julien Fauré; Nathalie Sartori Blanc; Stefan Matile; Jacques Dubochet; Rémy Sadoul; Robert G Parton; Francis Vilbois; Jean Gruenberg
Journal:  Science       Date:  2004-01-23       Impact factor: 47.728

2.  Identification of a novel proline-arginine motif involved in CIN85-dependent clustering of Cbl and down-regulation of epidermal growth factor receptors.

Authors:  Katarzyna Kowanetz; Iwona Szymkiewicz; Kaisa Haglund; Marcin Kowanetz; Koraljka Husnjak; Jonathan D Taylor; Philippe Soubeyran; Ulla Engstrom; John E Ladbury; Ivan Dikic
Journal:  J Biol Chem       Date:  2003-07-21       Impact factor: 5.157

3.  Identical splicing of aberrant epidermal growth factor receptor transcripts from amplified rearranged genes in human glioblastomas.

Authors:  N Sugawa; A J Ekstrand; C D James; V P Collins
Journal:  Proc Natl Acad Sci U S A       Date:  1990-11       Impact factor: 11.205

4.  Amplified and rearranged epidermal growth factor receptor genes in human glioblastomas reveal deletions of sequences encoding portions of the N- and/or C-terminal tails.

Authors:  A J Ekstrand; N Sugawa; C D James; V P Collins
Journal:  Proc Natl Acad Sci U S A       Date:  1992-05-15       Impact factor: 11.205

5.  Structural alterations of the epidermal growth factor receptor gene in human gliomas.

Authors:  A J Wong; J M Ruppert; S H Bigner; C H Grzeschik; P A Humphrey; D S Bigner; B Vogelstein
Journal:  Proc Natl Acad Sci U S A       Date:  1992-04-01       Impact factor: 11.205

6.  Anti-synthetic peptide antibody reacting at the fusion junction of deletion-mutant epidermal growth factor receptors in human glioblastoma.

Authors:  P A Humphrey; A J Wong; B Vogelstein; M R Zalutsky; G N Fuller; G E Archer; H S Friedman; M M Kwatra; S H Bigner; D D Bigner
Journal:  Proc Natl Acad Sci U S A       Date:  1990-06       Impact factor: 11.205

7.  Tyrphostin AG 1478 preferentially inhibits human glioma cells expressing truncated rather than wild-type epidermal growth factor receptors.

Authors:  Y Han; C G Caday; A Nanda; W K Cavenee; H J Huang
Journal:  Cancer Res       Date:  1996-09-01       Impact factor: 12.701

8.  Escape from Cbl-mediated downregulation: a recurrent theme for oncogenic deregulation of receptor tyrosine kinases.

Authors:  Pascal Peschard; Morag Park
Journal:  Cancer Cell       Date:  2003-06       Impact factor: 31.743

9.  SETA/CIN85/Ruk and its binding partner AIP1 associate with diverse cytoskeletal elements, including FAKs, and modulate cell adhesion.

Authors:  Mirko H H Schmidt; Baihua Chen; Lisa M Randazzo; Oliver Bogler
Journal:  J Cell Sci       Date:  2003-05-27       Impact factor: 5.285

10.  A mutant epidermal growth factor receptor common in human glioma confers enhanced tumorigenicity.

Authors:  R Nishikawa; X D Ji; R C Harmon; C S Lazar; G N Gill; W K Cavenee; H J Huang
Journal:  Proc Natl Acad Sci U S A       Date:  1994-08-02       Impact factor: 11.205

View more
  55 in total

1.  Structural recognition mechanisms between human Src homology domain 3 (SH3) and ALG-2-interacting protein X (Alix).

Authors:  Xiaoli Shi; Stephane Betzi; Adrien Lugari; Sandrine Opi; Audrey Restouin; Isabelle Parrot; Jean Martinez; Pascale Zimmermann; Patrick Lecine; Mingdong Huang; Stefan T Arold; Yves Collette; Xavier Morelli
Journal:  FEBS Lett       Date:  2012-05-26       Impact factor: 4.124

2.  Phosphorylation of the proline-rich domain of Xp95 modulates Xp95 interaction with partner proteins.

Authors:  Robert E Dejournett; Ryuji Kobayashi; Shujuan Pan; Chuanfen Wu; Laurence D Etkin; Richard B Clark; Oliver Bögler; Jian Kuang
Journal:  Biochem J       Date:  2007-01-15       Impact factor: 3.857

3.  Structural basis for endosomal targeting by the Bro1 domain.

Authors:  Jaewon Kim; Sujatha Sitaraman; Aitor Hierro; Bridgette M Beach; Greg Odorizzi; James H Hurley
Journal:  Dev Cell       Date:  2005-06       Impact factor: 12.270

Review 4.  The ESCRT complexes: structure and mechanism of a membrane-trafficking network.

Authors:  James H Hurley; Scott D Emr
Journal:  Annu Rev Biophys Biomol Struct       Date:  2006

5.  No strings attached: the ESCRT machinery in viral budding and cytokinesis.

Authors:  Bethan McDonald; Juan Martin-Serrano
Journal:  J Cell Sci       Date:  2009-07-01       Impact factor: 5.285

6.  In vitro budding of intralumenal vesicles into late endosomes is regulated by Alix and Tsg101.

Authors:  Thomas Falguières; Pierre-Philippe Luyet; Christin Bissig; Cameron C Scott; Marie-Claire Velluz; Jean Gruenberg
Journal:  Mol Biol Cell       Date:  2008-09-03       Impact factor: 4.138

Review 7.  Ubiquitination of E3 ligases: self-regulation of the ubiquitin system via proteolytic and non-proteolytic mechanisms.

Authors:  P de Bie; A Ciechanover
Journal:  Cell Death Differ       Date:  2011-03-04       Impact factor: 15.828

8.  Enhanced generation of intraluminal vesicles in neuronal late endosomes in the brain of a Down syndrome mouse model with endosomal dysfunction.

Authors:  Pasquale D'Acunzo; Tal Hargash; Monika Pawlik; Chris N Goulbourne; Rocío Pérez-González; Efrat Levy
Journal:  Dev Neurobiol       Date:  2019-08-01       Impact factor: 3.964

9.  A novel requirement for C. elegans Alix/ALX-1 in RME-1-mediated membrane transport.

Authors:  Anbing Shi; Saumya Pant; Zita Balklava; Carlos Chih-Hsiung Chen; Vanesa Figueroa; Barth D Grant
Journal:  Curr Biol       Date:  2007-11-08       Impact factor: 10.834

10.  Molecular basis for defect in Alix-binding by alternatively spliced isoform of ALG-2 (ALG-2DeltaGF122) and structural roles of F122 in target recognition.

Authors:  Tatsutoshi Inuzuka; Hironori Suzuki; Masato Kawasaki; Hideki Shibata; Soichi Wakatsuki; Masatoshi Maki
Journal:  BMC Struct Biol       Date:  2010-08-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.